SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-17-000445
Filing Date
2017-02-24
Accepted
2017-02-24 16:07:04
Documents
5
Period of Report
2017-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K entiabiosciences8k022416.htm 8-K 28188
2 EX-99.1 ex99-1.htm EX-99.1 9886
3 EX-99.2 ex99-2.htm EX-99.2 97742
4 EX-99.3 ex99-3.htm EX-99.3 32868
5 image0.jpg GRAPHIC 114242
  Complete submission text file 0001185185-17-000445.txt   327524
Mailing Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140
Business Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140 971-228-0709
Entia Biosciences, Inc. (Filer) CIK: 0001408299 (see all company filings)

IRS No.: 260561199 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52864 | Film No.: 17637198
SIC: 2833 Medicinal Chemicals & Botanical Products